Dr. Barry Katzen to Present CATANIA(TM) Coronary Stent Data in Tel Aviv

NEWNAN, Georgia, December 1 - CeloNova BioSciences, Inc., a provider of specialty surface treatments
for medical devices and of specialty implants, today announced that Barry
Katzen, MD, FACR, FACC, FSCAI, founder and medical director of Baptist
Cardiac & Vascular Institute in Miami, Florida, will discuss the CATANIA(TM)
Stent System with NanoThin Polyzene(R)-F at the Innovations in Cardiovascular
Interventions Conference to be held at the Hotel David InterContinental in
Tel Aviv, Israel, which will include new information about the stent's
coating, Polyzene(R)-F, and clinical outcomes in coronary, below-the-knee,
and neurovascular applications. "We are deeply honored that Dr. Katzen will
present these data at the ICI conference where innovation is recognized and
celebrated. We believe the CATANIA(TM) stent is the technological
breakthrough that interventional cardiologists have needed to dispense with
the problems associated with bare metal and drug-eluting stents," said Thomas
A. Gordy, President and chief Executive Officer of CeloNova. "Dr. Katzen is a
true pioneer in interventional medicine."

    (Logo: www.newscom.com/cgi-bin/prnh/20081001/CLW080LOGO-b )
    (Photo: www.newscom.com/cgi-bin/prnh/20081007/CLTU035-a )
    (Photo: www.newscom.com/cgi-bin/prnh/20081001/CLW080-c )

About CeloNova BioSciences: Headquartered in Newnan, Georgia, CeloNova
BioSciences, Inc., is a developer of novel medical devices that are enhanced
by one of the Company's proprietary materials, Polyzene(R)-F, a lubricious,
anti-thrombotic, anti-inflammatory, and bacterial-resistant surface treatment
for implanted medical devices. The Company's current products include
Embozene(TM) Color-Advanced Microspheres and the CATANIA(TM) Coronary Stent
System with NanoThin Polyzene(R)-F. Both products are CE Marked. Embozene(TM)
Microspheres have been approved by the FDA for the treatment of
hypervascularized tumors and arteriovenous malformations. For more
information, please visit www.celonova.com.

About Innovations in Cardiovascular Interventions: The ICI meeting for
interventional cardiologists, innovators, and industry will be held December
6-8, in Tel-Aviv, Israel. It is a continuation of the series of
interventional cardiology conferences held in Israel since 1995. The upcoming
meeting will focus on innovative technology, therapies, and research at
various levels of development, with thematic live case presentations to
present the impact of these technologies on current and future therapy.

Contact: Theresa Wilson +1-770-502-0304; +1-678-895-6486

Theresa Wilson +1-770-502-0304; +1-678-895-6486